Risk factors for stroke and the effect of cholesterol-lowering therapy with pravastatin

被引：0
作者：
West, M
White, H
Simes, R
Kirby, A
Anderson, N
Hankey, G
Tonkin, A
机构：
[1] Univ Queensland, Prince Charles Hosp, Brisbane, Qld, Australia
[2] Green Lane Hosp, Dept Cardiol, Auckland 3, New Zealand
[3] NHMRC Clin Trials Ctr, Sydney, NSW, Australia
[4] Univ Auckland, Sch Med, Auckland, New Zealand
[5] Royal Perth Hosp, Clin Neurosci Div, Perth, WA, Australia
[6] Heart Fdn Australia, Melbourne, Vic, Australia
来源：
JOURNAL OF HYPERTENSION | 2000年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：S17 / S17
页数：1
相关论文
共 50 条
  • [21] Need to individualise cholesterol-lowering therapy
    Luetjohann, Dieter
    Weingaertner, Oliver
    [J]. HEART, 2019, 105 (16)
  • [22] The future direction of cholesterol-lowering therapy
    Evans, M
    Roberts, A
    Rees, A
    [J]. CURRENT OPINION IN LIPIDOLOGY, 2002, 13 (06) : 663 - 669
  • [23] Pharmacogenetics and pharmacogenomics of cholesterol-lowering therapy
    Schmitz, Gerd
    Schmitz-Madry, Anna
    Ugocsai, Peter
    [J]. CURRENT OPINION IN LIPIDOLOGY, 2007, 18 (02) : 164 - 173
  • [24] Cholesterol-lowering therapy: Is there really a controversy?
    Jungnickel, PW
    [J]. ANNALS OF PHARMACOTHERAPY, 1996, 30 (05) : 539 - 542
  • [25] Pleiotropic Effects and Cholesterol-Lowering Therapy
    Shaw, Steven M.
    Fildes, James E.
    Yonan, Nizar
    Williams, Simon G.
    [J]. CARDIOLOGY, 2009, 112 (01) : 4 - 12
  • [26] Pharmacogenomics and pharmacogenetics of cholesterol-lowering therapy
    Schmitz, G
    Drobnik, W
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2003, 41 (04) : 581 - 589
  • [27] EFFECT OF CHOLESTEROL-LOWERING MEDICATIONS ON PROGRESSION OF MILD ATHEROSCLEROTIC LESIONS OF THE CAROTID ARTERIES AND ON THE RISK OF STROKE
    ADAMS, HP
    BYINGTON, RP
    HOEN, H
    DEMPSEY, R
    FURBERG, CD
    [J]. CEREBROVASCULAR DISEASES, 1995, 5 (03) : 171 - 177
  • [28] The effect of cholesterol-lowering therapy on the progression of diabetic nephropathy is unproved
    Bender, R
    [J]. DIABETOLOGIA, 1996, 39 (03) : 368 - 369
  • [29] Statin therapy and reduced incidence of stroke - Implications of cholesterol-lowering therapy for cerebrovascular disease
    Gotto, AM
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (12) : 1283 - 1284
  • [30] Influence of Previous Statin Therapy on Cholesterol-Lowering Effect of Ezetimibe
    Choi, Young Hwan
    Kim, Young
    Hyeon, Cheol Won
    Hyun, Seonghyup
    Kwon, Jee Eun
    Won, Hoyoun
    Shin, Seung Yong
    Lee, Wang-Soo
    Lee, Kwang Je
    Kim, Sang-Wook
    Kim, Tae Ho
    Kim, Chee Jeong
    [J]. KOREAN CIRCULATION JOURNAL, 2014, 44 (04) : 227 - 232
12345